Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10165077 | JACC: Heart Failure | 2015 | 10 Pages |
Abstract
Transvenous, unilateral phrenic nerve stimulation appears safe and effective for treating CSA. These findings should be confirmed in a prospective, randomized, controlled trial. (Chronic Evaluation of Respicardia Therapy; NCT01124370)
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
William T. MD, Dariusz MD, Olaf MD, Ralph MD, Steven MD, Adam MD, Klaus-Jürgen MD, Rami MD, Andrew MD, Manya R. MS, Richard G. PhD, Shahrokh MD, Piotr MD, PhD, remedÄ Pilot Study Investigators remedÄ Pilot Study Investigators,